About 2 results found for searched term "Atrasentan" (0.134 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M8766 | Atrasentan hydrochloride | Endothelin Receptor |
| ABT-627 hydrochloride; Abbott 147627 | ||
| Atrasentan hydrochloride (ABT-627 hydrochloride) is a potent, orally active, selective endothelin A (ETA) receptor antagonist that inhibits ETA activity and blocks endothelin-induced cellular proliferation with an IC50 value of 0.0551 nM. It can be used in studies related to prostate cancer as well as IgA nephropathy (IgAN). It can be used in prostate cancer and IgA nephropathy (IgAN) related studies. | ||
| M21788 | Atrasentan | Endothelin Receptor |
| ABT-627 | ||
| Atrasentan is a selective, orally active endothelin A (ETA) receptor antagonist. It can be used in studies related to glomerular disease and diabetic nephropathy. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
